Table of Contents
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): August 5, 2004
DYNAVAX TECHNOLOGIES CORPORATION
Commission File Number: 000-1029142
| Delaware | 33-0728374 | |
| (State or Other Jurisdiction of Incorporation) | (I.R.S. Employer Identification No.) |
717 Potter Street, Suite 100
Berkeley, CA 94710-2722
(Address of Principal Executive Offices including zip code)
(510) 848-5100
(Registrant’s Telephone Number, Including Area Code)
| Item 7. Financial Statements and Exhibits. | ||||||||
| Item 12. Results of Operations and Financial Condition. | ||||||||
| SIGNATURES | ||||||||
| EXHIBIT 99.1 | ||||||||
Table of Contents
Item 7. Financial Statements and Exhibits.
c. Exhibits
| Exhibit No. | Description | |
| 99.1 | Press release of Dynavax Technologies Corporation, dated August 5, 2004. |
Item 12. Results of Operations and Financial Condition.
On August 5, 2004, the Company issued a press release relating to the Company’s earnings for the second quarter of fiscal year 2004. A copy of the press release is attached as Exhibit 99.1.
The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 12 and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.
2
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| DYNAVAX TECHNOLOGIES CORPORATION | ||||
| Date: August 5, 2004 | By: | /s/ Dino Dina | ||
| Dino Dina, M.D. | ||||
| President, Chief Executive Officer and Acting Chief Financial Officer | ||||
3